https://www.selleckchem.com/pr....oducts/cct245737.htm
Itraconazole prophylaxis reduces risk for histoplasmosis in patients with CD4 counts less then 100/µL but is not associated with survival benefit and is primarily reserved for use in outbreaks. Although most patients with histoplasmosis have not had recognized high-risk exposures, avoidance of contact with bird or bat guano or inhalation of aerosolized soil in endemic regions may reduce risk. Adherence to effective antiretroviral therapy is the most important strategy for reducing the incidence of life-threatening histoplasmosis.Progr
Like
Comment
Share
